Sun, 23 Jan 2022 18:51:05: Less selling, more science can best help doctors navigate complex new cancer treatments, report suggests

Fri, 21 Jan 2022 16:04:19: Fierce JPM Week: Bristol Myers' next-gen autoimmune med not just another JAK drug, exec says

Fri, 21 Jan 2022 14:50:58: GlaxoSmithKline rushes to accelerate COVID-19 antibody output amid omicron-driven demand

Fri, 21 Jan 2022 12:07:49: You say Trintellix, I say Brintellix: Why a drug name in the US won't always translate across the pond

Fri, 21 Jan 2022 11:45:56: Fierce Pharma Asia—Lilly-Abbisko cardiometabolic pact; Daiichi Sankyo asset sale; Eisai's next Alzheimer's prospect

Fri, 21 Jan 2022 03:25:18: Ogilvy Health's new creative chief Hessel reflects on pharma's pandemic opportunities

Thu, 20 Jan 2022 14:48:07: Goodbye Humira, hello Dupixent: Sanofi and Regeneron outspend AbbVie to top 2021’s pharma TV ad spenders

Thu, 20 Jan 2022 14:41:53: Viatris yanks one batch of diabetes med Semglee because of missing label risks

Thu, 20 Jan 2022 14:30:33: Merck scores a win in $1.4B insurance fight over devastating cyberattack

Thu, 20 Jan 2022 13:47:24: Merck's Clyburn headed for the exit, opening top human health spot at the New Jersey pharma giant

Thu, 20 Jan 2022 12:39:53: Doceree offers glimpse into trends of 'programmatic marketing'

Thu, 20 Jan 2022 11:49:35: COVID vaccines help Pfizer, Moderna reign supreme reputation-wise, but they're a double-edged sword for J&J and AZ

Wed, 19 Jan 2022 17:51:53: Fierce JPM Week: Novo Nordisk plans more patient outreach, doctor education as Wegovy launch works through supply woes

Wed, 19 Jan 2022 14:41:59: Did BMS set up a subsidiary to avoid paying $1.4B in US taxes? The Senate finance chairman is on the case

Wed, 19 Jan 2022 05:04:29: Apprentice.io scores $100M funding for augmented reality tech that helped drug plants work through COVID-time

Tue, 18 Jan 2022 19:40:53: Fierce JPM Week: Despite pandemic's challenges, collaboration in biopharma is 'alive and well,' panel says

Tue, 18 Jan 2022 15:44:43: The wait is over: AbbVie's Rinvoq chalks up FDA win with favorable atopic dermatitis label

Tue, 18 Jan 2022 14:39:05: Inside the Catalent FDA citation said to trigger Novo Nordisk's Wegovy supply hiccup

Tue, 18 Jan 2022 11:46:01: Fierce JPM Week: 5 industry execs discuss pandemic supply chain issues, solutions

Fri, 14 Jan 2022 22:31:07: Tapping new tech helps marketers matchmake rare disease drugs for elusive patients

Fri, 14 Jan 2022 21:34:05: Shkreli hit with $64.6M verdict, lifetime pharma ban in antitrust case

Fri, 14 Jan 2022 20:56:01: After delays, Pfizer's blockbuster-to-be eczema drug Cibinqo snags FDA nod

Fri, 14 Jan 2022 18:21:01: Novo Nordisk comes out clean in $1.8B investor lawsuit alleging insulin misdirection

Fri, 14 Jan 2022 16:48:57: Emergent BioSolutions founder El-Hibri bids adieu after CDMO's turbulent 2021

Fri, 14 Jan 2022 15:27:44: JPM 2022: With Voxzogo approvals adding up, BioMarin is underway with its 'biggest launch,' CEO says